APA (7th ed.) Citation

JS, F. (2024). Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing Clinical Trials During Unexpected Outbreaks. Journal of the American College of Cardiology, 84(17), 1643. https://doi.org/10.1016/j.jacc.2024.08.035

Chicago Style (17th ed.) Citation

JS, Faust. "Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing Clinical Trials During Unexpected Outbreaks." Journal of the American College of Cardiology 84, no. 17 (2024): 1643. https://doi.org/10.1016/j.jacc.2024.08.035.

MLA (9th ed.) Citation

JS, Faust. "Semaglutide, COVID-19 Mortality, and the Power of Harnessing Ongoing Clinical Trials During Unexpected Outbreaks." Journal of the American College of Cardiology, vol. 84, no. 17, 2024, p. 1643, https://doi.org/10.1016/j.jacc.2024.08.035.